U.S. markets closed

  • S&P Futures

    4,343.00
    -9.00 (-0.21%)
     

  • Dow Futures

    34,797.00
    -67.00 (-0.19%)
     

  • Nasdaq Futures

    14,755.75
    -31.75 (-0.21%)
     

  • Russell 2000 Futures

    2,179.90
    -6.90 (-0.32%)
     

  • Crude Oil

    71.35
    -0.30 (-0.42%)
     

  • Gold

    1,830.10
    +1.10 (+0.06%)
     

  • Silver

    26.43
    +0.06 (+0.21%)
     

  • EUR/USD

    1.1819
    0.0000 (-0.00%)
     

  • 10-Yr Bond

    1.2970
    -0.0590 (-4.35%)
     

  • Vix

    17.01
    +0.68 (+4.16%)
     

  • GBP/USD

    1.3832
    +0.0009 (+0.06%)
     

  • USD/JPY

    109.7300
    -0.1100 (-0.10%)
     

  • BTC-USD

    31,702.93
    -1,042.26 (-3.18%)
     

  • CMC Crypto 200

    767.09
    -19.34 (-2.46%)
     

  • FTSE 100

    7,012.02
    -79.17 (-1.12%)
     

  • Nikkei 225

    28,279.09
    0.00 (0.00%)
     

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Stable Road Acquisition Corp. – SRAC

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Pomerantz LLP
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Stable Road Acquisition Corp. (“Stable Road” or the “Company”) (NASDAQ: SRAC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Stable Road and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On July 13, 2021, the U.S. Securities and Exchange Commission (“SEC”) announced that it had brought charges against the special-purpose acquisition company (“SPAC”) Stable Road in connection with its acquisition of Momentus Inc. (“Momentus”). Among other things, the SEC has alleged that Momentus lied about its technology, including falsely claiming that its propulsion system had been ‘successfully tested’ in space, ad that Stable Road repeated Momentus’s misleading statements in public filings, while failing to conduct adequate due diligence of Momentus.

On this news, Stable Road’s stock price fell $1.22 per share, or 10.27%, to close at $10.66 per share on July 14, 2021.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com


Recommended Stories

  • Why NVIDIA Stock Just Dropped 4%

    What happened Shares of graphics (and crypto-mining) chipmaker NVIDIA (NASDAQ: NVDA) tumbled for a third straight day Thursday, falling 4% in 1:25 p.m. EDT trading despite getting a boost in its price target from Wall Street bank Mizuho.

  • Bond King Jeff Gundlach says there is a simple reason Treasury yields are so low even as inflation surges

    Bond guru Jeffrey Gundlach of DoubleLine Capital said it is no mystery why U.S. Treasury yields are anchored lower despite evidence that inflation is rising in an economy attempting to rebound from a stultifying pandemic.

  • NVIDIA Stock Could Crash. Here's What You Should Do if It Does

    As graphics card prices start sliding, NVIDIA investors may have to relive a torrid time in the company's history.

  • Why Moderna Stock Is Hitting Another Record High Today

    Shares of Moderna (NASDAQ: MRNA) were jumping 4.3% as of 11:10 a.m. EDT on Thursday, hitting another record high for the stock. The bump came after Michael Yee, an analyst at Jefferies, increased his price target on the stock from $170 to $250. Also, Dr. Marco Cavaleri, the European Medicines Agency (EMA) head of biological health threats and vaccines strategy, stated in a press conference that a committee would likely finalize a decision on recommending authorization for Moderna's COVID-19 vaccine in children by the end of next week.

  • 'We think that there’s going to be more upside to Apple here': Citi's Jim Suva

    Jim Suva, Citi Managing Director in Equity Research specializing in technology, joined Yahoo Finance Live to break down his thoughts ont he outlook of Apple. 

  • Expect a 10% or worse correction in U.S. stocks by mid-August, says this forecaster with a proven track record

    In May 2020, I concluded that “the stock market… is stronger than even the most bullish investors believe.” In January of this year, I wrote that the market was still “firing on all cylinders.” In an interview on July 14, Martin said the U.S. stock market today is most definitely not firing on all cylinders. In fact, he said, the market’s internal health is now worse than at any time since October 2018.

  • Why Is Lordstown Motors Stock Higher Today?

    Shares of embattled electric pickup start-up Lordstown Motors (NASDAQ: RIDE) were trading higher on Thursday. In March, short-seller Hindenburg Research alleged that Lordstown (among other things) exaggerated the number of pre-orders it had for its Endurance pickup truck. Lordstown denied the allegations, but the Securities and Exchange Commission opened an investigation.

  • 10 Best Safe Blue Chip Dividend Stocks

    In this article, we will be looking at the 10 best safe blue chip dividend stocks. If you want to skip our detailed analysis of blue chips stocks and dividend investing, you can go directly to the 5 Best Safe Blue Chip Dividend Stocks. If you’re looking for a stock that’s reliable, renowned, and reputable, […]

  • Why Virgin Galactic Shares Fell This Week

    Virgin Galactic Holdings (NYSE: SPCE) completed a historic milestone last Sunday, successfully launching founder Richard Branson into space. Branson's flight into space happened nearly a year after it was originally planned, due to a combination of COVID-related delays and some testing setbacks. Richard Branson (second from left) and the mission specialists ahead of the July 11 flight.

  • Why Is Everyone Talking About General Electric Stock?

    General Electric (NYSE: GE) stock is sitting in the middle of a battleground of bulls and bears. The bears point out that the stock is up less than 12% compared to the near 50% gain in the S&P 500 since October 2018, when Larry Culp took over as GE's CEO. GE is a company that remains poorly run despite Culp's efforts, and faces significant end market challenges in aviation (slow recovery in commercial air flights) and power (weak demand for gas turbines over renewable energy).

  • My Top Oil Stock to Buy Right Now

    When you look at the oil industry, this European giant still stands out as the best mix of risk and reward.

  • Citigroup Just Raised Its Price Target on AMD Stock by 459%. Here’s Why.

    Analyst Christopher Danely upgraded his call on AMD to Neutral from Sell, and bumped his price target to $95 from $17. The loser: Intel.

  • Better Electric Vehicle Charging Stock: ChargePoint or Blink Charging

    Similarly, ChargePoint (NYSE: CHPT) stock is up roughly 155% since it announced plans to go public via a special purpose acquisition company last September. To begin with, ChargePoint is bigger than Blink Charging in terms of number of charging stations, revenue, and market share.

  • Why Plug Power, Nikola, and JinkoSolar Stocks Popped Today

    Plug just barely, while Nikola's 3.4% and Jinko's 4.5% gains remain more respectable. In the case of Plug Power, the answer is easy: An upgrade -- or more precisely, a new buy rating, from Seaport Global Securities, which initiated coverage of the $26 stock today with a price target of $36.

  • 3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street

    Despite the stock market hitting seemingly one new high after another since the year began, Wall Street still sees value in equities. Based on the highest Wall Street price target for each of the following small-cap stocks, implied upside ranging from 158% to as much as 329% may await. The first tiny tot that Wall Street appears to be really excited about is clinical-stage biotech stock Vaxart (NASDAQ: VXRT).

  • Why Appian, Fastly, Fiverr, and LivePerson All Fell This Week

    Shares of Appian (NASDAQ: APPN), Fastly (NYSE: FSLY), Fiverr International (NYSE: FVRR), and LivePerson (NASDAQ: LPSN) were all sliding this week as high-priced growth stocks largely pulled back on inflation concerns. There was no major news out on these stocks, but with June's consumer price index report showing inflation was hotter than expected, fears of tightening monetary policy from the Federal Reserve seemed to have cooled off these pricey stocks. Through Thursday at 1:19 p.m EDT, Appian was down 13.9% for the week, Fastly had lost 12.6%, Fiverr had given up 12.5%, and LivePerson was down 9.9%.

  • 10 Best Dividend Kings to Buy Now According to Hedge Funds

    In this article, we will be looking at the 10 best dividend kings to buy now according to hedge funds. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 Best Dividend Kings to Buy According to Hedge Funds. The economic and financial volatility that came as […]

  • EV Charging Stock Jumps On Expanded GM Alliance

    GM expanded its new EV charging service to include commercial vehicles and named EVgo a preferred partner.

  • Moderna Climbs as S&P 500 Set to Welcome Covid Vaccine Maker

    (Bloomberg) -- Moderna Inc. climbed more than 6% in extended trading Thursday after the vaccine maker was named to the S&P 500 Index in one of the most noteworthy additions to the index since Tesla Inc. joined late last year.The company, whose messenger-RNA vaccine has helped to fight the Covid-19 pandemic, will replace Alexion Pharmaceuticals Inc. in the benchmark U.S. index before the opening of trading on July 21. Alexion is set to be acquired by U.K. drugmaker AstraZeneca Plc.Shares of Moder

  • Goldman Sachs Sees These 3 Stocks Skyrocketing Over 60%

    The S&P 500 has been rising all year, and to date has posted gains of more than 16%. After a more volatile start to the year, with strong swings up and down from January to the end of May, during which investors pulled back from the tech giants, the NASDAQ has joined the upward trend. Its year-to-date gain now stands at 14%, and like the S&P, sits just under a record high level. But how much room is there for further growth across the board? In an environment like this, investors need to take ca